Summary
Obesity is a chronic, usually life-long condition. Therefore, the success of any treatment should be measured by the long-term weight loss. More patients lose weight than maintain the weight loss after the active phase of therapy has ended.
Conservative approaches like dietary restrictions or behavior modification techniques have been only modestly successful in weight maintenance. Both are, therefore, suitable for patients with milder degrees of obesity. Anorexicants seem to have specific but limited use in the treatment of obesity. Fasting and protein sparing modified fast are indicated for patients with a high degree of obesity, i.e. for those who are at least 30% or 25 kg or more over their ideal body weight. Both these procedures have definite risks. Rapid weight loss is induced by fasting but long-term follow-ups showed gradual regain of weight loss. Combinations of various techniques such as behavior modification, exercise, proper nutritional instruction and protein-sparing modified fast seem to have the best chance for long-term success.
Zusammenfassung
Die Fettsucht ist ein chronischer, meist lebenslanger Zustand. Ein über längere Zeit anhaltender Gewichtsverlust ist deshalb der beste Meßpunkt eines Behandlungserfolgs. Es gibt allerdings mehr Patienten, die abnehmen, als solche, die ihre Gewichtsabnahme noch nach Beendigung der aktiven Behandlungsphase beibehalten.
Konservative Maßnahmen, wie Diät oder Verhaltenstherapie, sind nur mäßig erfolgreich das Gewicht beizubehalten. Sie eignen sich daher nur für wenig übergewichtige Patienten. Anorexika spielen eine spezifische aber begrenzte Rolle bei der Behandlung der Fettsucht. Fasten und „protein-sparing modified fast“ sind indiziert bei Patienten mit hochgradiger Fettsucht, d.h. Patienten, die mindestens 30% bzw. 25 kg mehr als ihr ideales Gewicht wiegen. Beide Methoden sind mit besonderen Risiken verbunden. Fasten führt zwar zu einem schnellen Gewichtsverlust, aber nach einiger Zeit nimmt der Patient allmählich wieder zu. Die Kombination verschiedener Methoden, wie Verhaltenstherapie, physische Aktivität, angemessene Anweisungen über Ernährung und „protein-sparing modified fast“ scheinen die besten Aussichten auf einen anhaltenden Erfolg zu bieten.
Similar content being viewed by others
References
Bray GA (ed) (1979) Obesity in America, Vol. 4. NIH Publication No 79–359
Abraham S, Johnson CL (1980) Prevalence of severe obesity in adults in the United States. Am J Clin Nutr 33:364–369
Drenick EJ, Bale GS, Seltzer F et al. (1980) Excessive mortality and causes of death in morbidly obese men. JAMA 243:443–445
Christakis G (1967) Community programs for weight reduction: Experience of the Bureau of Nutrition, New York City, Can J Public Health 58:499–504
Seaton DA, Rose K (1965) Defaulters from a weight reduction clinic. J Chronic Dis 18:1007–1011
Craddock D (1969) Obesity and its management. E&S Livingston, Edinburgh London, The Williams and Wilkins, Baltimore, p 116
Fellows HH (1931) Studies of relatively obese individuals during and after dietary restrictions. AM J Med Sci 181:301–312
Stunkard A, McLaren-Hume M (1959) The results of treatment for obesity. A review of the literature and report of a series. AMA Arch Intern Med 103:79–85
Glennon JA (1966) Weight reduction — an enigma. Arch Intern Med 118:1–2
Sohar E, Sheh E (1963) Follow-up of obese patients; 14 years after a successful reducing diet. Am J Clin Nutr 26:845–848
Stuart RB (1967) Behavioral control of overeating. Behav Res Ther 5:357–365
Stunkard AJ, Penick SB (1979) Behavior modification in the treatment of obesity. The problem of maintaining weight loss. Arch Gen Psychiatry 36:801–806
Currey H, Malcolm R, Riddle E et al. (1977) Behavioral treatment of obesity. Limitations and results with the chronically obese. JAMA 237:2829–2831
Linet OI, Metzler CM, van Tassel M (1979) Evaluation of a “free” weight control clinic. Obesity/Bariatric Med 8:152–157
Rooth G, Carlström S (1970) Therapeutic fasting. Acta Med Scand 187:455–463
MacCuish AC, Munro JF, Duncan LJP (1968) Follow-up study of refractory obesity treated by fasting. Br Med J 1:91–92
Gilliland IC (1968) Total fasting in the treatment of obesity. Postgrad Med J 44:58–61
Duncan GG, Hunscher MA, Cristofori FC et al. (1965) Intermittent total fasts and obesity. Indications, results and preventable hazards. Postgrad Med 38:523–535
Hunscher MA (1966) A post-hospitalization study of patients treated for obesity by a total fast regimen. Metabolism 15:383–393
Berger M, Granz M, Berchtold P et al. (1976) Verlaufsuntersuchungen zum Langzeiteffekt der Nulldiät. Dtsch Med Wochenschr 101:601–605
Bayer PM, Fegal U, Pointner H (1977) Langzeitergebnisse nach Nullkalorien-Diät. Wiener Klin Wochenschr 89:222–224
Hermann LS, Iversen M (1968) Death during therapeutic starvation. Lancet 2:217
Göschke H, Hausser R, Lauffenburger T et al. (1976) Langzeiterfolg von Fastenkuren. Resultate von 132 konsekutiven Patienten nach 1–6 1/2 Jahren. Schweiz Med Wochenschr 106:713–717
Johnson D, Drenick EJ (1977) Therapeutic fasting in morbid obesity. Arch Intern Med 137:1381–1382
Hoffman R (1978) Starvation diets in the treatment of obesity. Obesity/Bariatric Med 7:10–20
Lindner PG, Blackburn GL (1976) Multidisciplinary approach to obesity utilizing fasting modified by protein-sparing therapy. Obesity/Bariatric Med 5:198–216
Bistrian BR (1978) Clinical use of a protein-sparing modified fast. JAMA 240:2299–2302
Blackburn L, Bistrian R, Flatt JP (1974) In: Howard A (ed) Recent advances in obesity research. Technomic Publishing Company, Westport, pp 279–281
Vertes V, Genuth SM, Hazelton M (1977) Supplemented fasting as a large-scale outpatient program. JAMA 238:2151–2153
Linn R, Stuart SL (1976) The last chance diet. Lyle Stuart, Secaucus, NJ
FDA Drug Bulletin (1978) Liquid protein and sudden cardiac deaths — an update. 8:18–19
Bistrian BR, Sherman M (1978) Results of the treatment of obesity with a protein-sparing modified fast. Intern J Obesity 2:143–148
Lindner P (1979) Personal communication
Yang SP, Martin LJ, Schneider G (1980) Weight reduction utilizing a protein-sparing modified fast. J Am Diet Assoc 76:343–346
Gotto AM, Vertes V, Jackson D (1980) Obesity — a new approach to an old problem. Heart and Lung 9:719–725
Scoville BA (1975) In: Bray GA (ed) Obesity in perspective. Fogarty International Center on Preventive Medicine, Washington, DC, DHEW Publication No (NIH) 75–708, pp 441–443
Lasagna L (1980) In: Stunkard AJ (ed) Obesity. Saunders, Philadelphia, pp 292–299
Enzi G, Baritussio A, Marchiori E et al. (1976) Short-term and long-term clinical evaluation of a non-amphetamine anorexiant (Mazindol) in the treatment of obesity. J Int Med Res 4:304–318
Hudson KD (1977) The anorectic and hypotensive effect of fenfluramine in obesity. J Roy Coll G P 27:497
Munro JF (1979) Clinical aspects of the treatment of obesity by drug: a review. Int J Obesity 3:171–180
Stunkard AJ, Wilcoxon Craighead L, O'Brien R (1980) Controlled trial of behaviour therapy, pharmacotherapy, and their combination in the treatment of obesity. Lancet 2:1045–1047
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Linet, O.I. Long-term efficacy of medical treatments for obesity. Klin Wochenschr 60, 115–120 (1982). https://doi.org/10.1007/BF01711275
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01711275
Key words
- Obesity
- Weight loss maintenance
- Diet
- Behavior modification
- Fast
- Protein sparing modified fast
- Anorexicants